Golcadomide
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Golcadomide, covering 2024-10-15 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy [Phase 1, Phase 2]